โšกToday
โœจToday's leadDoctors Complete First Bone Marrow Transplant From Deceased Donor for Non-Malignant Disease๐ŸŽˆFor kidsSouth Carolina tract beside wildlife refuge to be permanently conserved๐ŸŒฟNatureFormer ocean liner S.S. United States becomes the world's largest artificial reefโšฝSportsLindy Duncan wins her first LPGA title on attempt 222๐ŸŽจCulture & ideasA Lost Altdorfer Landscape Surfaces After 70 Years Privately Held๐Ÿ”ฌScience & healthPeople who control HIV without treatment may help find a cure๐Ÿ’›KindnessA laid-off man began mowing lawns for free and 2,100 volunteers joined๐Ÿ›๏ธPoliticsLos Angeles bans oil drilling after a decade of neighborhood pressure๐Ÿš€ProgressPhiladelphia repaired a collapsed interstate in 12 days

Hong Kong to trial non-invasive sound wave treatment for kidney tumours

South China Morning Post 11 November 2026 2 min read

โฎ BeforeHong Kong had no clinical trials of this non-invasive kidney tumour treatment.
โœ… NowThirty patients will get places in trials across three private hospitals.

In short

  • Li Ka-shing funds places for 30 patients in the trials.
  • Three private hospitals will run them: CUHK Medical Centre, Gleneagles Hospital Hong Kong and Hong Kong Sanatorium & Hospital.
  • The technique, histotripsy, uses focused sound waves to break apart tumours without surgical incisions.

Why it's good news

Histotripsy aims to treat tumours without the cuts of surgery. The Li Ka Shing Foundation is paying for places in the trials, which start at three private hospitals in Hong Kong. These are early clinical trials, so the treatment's benefits and safety are still being tested.

Advertisement

From South China Morning Post

Hong Kong will become the first city in Asia to conduct clinical trials of a non-invasive treatment for kidney tumours, with tycoon Li Ka-shing funding places for 30 patients across three private hospitals. The Li Ka Shing Foundation announced on Wednesday that CUHK Medical Centre, Gleneagles Hospital Hong Kong and Hong Kong Sanatorium & Hospital would launch the trials using histotripsy, a technology that uses focused sound waves to break apart tumours without surgical incisions. The trials...

Read the full story at South China Morning Post Opens the publisher's site in a new tab.

Ask this story

An AI model answers from the material behind this story only, with a link to the source. Your question is sent to our AI provider and isn't stored. See Privacy.

More like this

Advertisement
AdMobile anchor